J
James A. Delmez
Researcher at Washington University in St. Louis
Publications - 92
Citations - 10151
James A. Delmez is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Hemodialysis & Calcitriol. The author has an hindex of 46, co-authored 92 publications receiving 9823 citations. Previous affiliations of James A. Delmez include University of Utah & University of Alabama.
Papers
More filters
Journal ArticleDOI
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Garabed Eknoyan,Gerald J. Beck,Alfred K. Cheung,John T. Daugirdas,Tom Greene,John W. Kusek,Michael Allon,James L. Bailey,James A. Delmez,Thomas A. Depner,Johanna T. Dwyer,Andrew S. Levey,Nathan W. Levin,Edgar L. Milford,Daniel B. Ornt,Michael V. Rocco,Gerald Schulman,Steve J. Schwab,Brendan P. Teehan,Robert D. Toto +19 more
TL;DR: Patients undergoing hemodialysis thrice weekly appear to have no major benefit from a higher dialysis dose than that recommended by current U.S. guidelines or from the use of a high-flux membrane.
Journal ArticleDOI
Cardiac troponin I. A marker with high specificity for cardiac injury.
Jesse E. Adams,Geza S. Bodor,Victor G. Dávila-Román,James A. Delmez,Fred S. Apple,Jack H. Ladenson,Allan S. Jaffe +6 more
TL;DR: Measurement of cardiac troponin I (cTnI) has sufficient specificity to clarify the etiology of MBCK elevations in patients with acute or chronic skeletal muscle disease or renal failure, and Elevations of cTNI are highly specific for myocardial injury.
Journal ArticleDOI
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis: A Randomized Controlled Trial
Laura M. Dember,Gerald J. Beck,Michael Allon,James A. Delmez,Bradley S. Dixon,Arthur Greenberg,Jonathan Himmelfarb,Miguel A. Vazquez,Jennifer J. Gassman,Tom Greene,Milena Radeva,Gregory Braden,T. Alp Ikizler,Michael V. Rocco,Ingemar Davidson,James S. Kaufman,Catherine M. Meyers,John W. Kusek,Harold I. Feldman +18 more
TL;DR: Clopidogrel reduces the frequency of early thrombosis of new arteriovenous fistulas but does not increase the proportion of fistulas that become suitable for dialysis.
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis
Laura M. Dember,Gerald J. Beck,Michael Allon,James A. Delmez,Bradley S. Dixon,Arthur Greenberg,Jonathan Himmelfarb,Miguel A. Vazquez,Jennifer J. Gassman,Tom Greene,Milena Radeva,Gregory Braden,T. Alp Ikizler,Michael V. Rocco,Ingemar Davidson,James S. Kaufman,Catherine M. Meyers,John W. Kusek,Harold I. Feldman +18 more
TL;DR: In this article, the Dialysis Access Consortium (DACA) study group presented a study of the Dialysysmosis Access Consortium and its relationships with the following physicians:Laura M. Dember, MDGerald J. Beck, PhDMichael Allon, MDJames A. Delmez, MDBradley S. Dixon, MDArthur Greenberg, MDJonathan Himmelfarb, MDMiguel A. Vazquez, MDJennifer J. Radeva, MSGregory L. Braden, MDT.
Journal ArticleDOI
Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
Eduardo Slatopolsky,Carol Weerts,S. Lopez-Hilker,Kathryn Norwood,Mary Zink,David W. Windus,James A. Delmez +6 more
TL;DR: Calcium carbonate successfully lowered serum phosphorus levels and raised serum calcium levels in the majority of the authors' patients, thereby confirming that this agent may be a satisfactory substitute for traditional phosphate binders that contain aluminum.